- Home
- BEDU vs VTGN Comparison
BEDU vs VTGN Comparison
Compare BEDU & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- VTGN
- Stock Information
- Founded
- BEDU 1994
- VTGN 1998
- Country
- BEDU United Kingdom
- VTGN United States
- Employees
- BEDU N/A
- VTGN N/A
- Industry
- BEDU Other Consumer Services
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- BEDU Real Estate
- VTGN Health Care
- Exchange
- BEDU Nasdaq
- VTGN Nasdaq
- Market Cap
- BEDU 54.0M
- VTGN 59.8M
- IPO Year
- BEDU 2017
- VTGN N/A
- Fundamental
- Price
- BEDU $1.85
- VTGN $3.08
- Analyst Decision
- BEDU
- VTGN
- Analyst Count
- BEDU 0
- VTGN 0
- Target Price
- BEDU N/A
- VTGN N/A
- AVG Volume (30 Days)
- BEDU 2.3K
- VTGN 374.7K
- Earning Date
- BEDU 08-01-2025
- VTGN 08-12-2025
- Dividend Yield
- BEDU N/A
- VTGN N/A
- EPS Growth
- BEDU N/A
- VTGN N/A
- EPS
- BEDU N/A
- VTGN N/A
- Revenue
- BEDU $224,321,752.00
- VTGN $486,000.00
- Revenue This Year
- BEDU N/A
- VTGN $23.83
- Revenue Next Year
- BEDU N/A
- VTGN $660.39
- P/E Ratio
- BEDU N/A
- VTGN N/A
- Revenue Growth
- BEDU N/A
- VTGN N/A
- 52 Week Low
- BEDU $1.35
- VTGN $1.90
- 52 Week High
- BEDU $2.41
- VTGN $3.79
- Technical
- Relative Strength Index (RSI)
- BEDU 58.50
- VTGN 75.81
- Support Level
- BEDU $1.76
- VTGN $2.25
- Resistance Level
- BEDU $1.91
- VTGN $2.83
- Average True Range (ATR)
- BEDU 0.05
- VTGN 0.21
- MACD
- BEDU 0.01
- VTGN 0.07
- Stochastic Oscillator
- BEDU 63.89
- VTGN 84.16
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.